Description
This peptide is a CD8+ T cell epitope of HIV-1 reverse transcriptase (RT) subtype A2.1. This peptide may be used in the design of HIV vaccines, as it includes a target sequence that is recognizable by cytotoxic lymphocytes.
HIV Reverse Transcriptase A2.1 Peptide
Product ID H3278
Cas No.
Purity ≥95%
| Product Unit Size | Cost | Quantity | Stock |
|---|
Product Info
| Purity | ≥95% |
|---|---|
| Formula | C46H78N12O12 |
| Formula Wt. | 991.21 |
| Synonym | HIV-1 RT Epitope, IV9 (476-484) |
| Solubility | Soluble in water. |
| Appearance | White to off white powder |
Shipping and Storage
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
Downloads
| Info Sheet |
|---|
References
Peter K, Men Y, Pantaleo G, et al. Induction of a cytotoxic T-cell response to HIV-1 proteins with short synthetic peptides and human compatible adjuvants. Vaccine. 2001 Jul 20;19(30):4121-9. PMID: 11457536.
Shankar P, Sprang H, Lieberman J. Effective lysis of HIV-1-infected primary CD4+ T cells by a cytotoxic T-lymphocyte clone directed against a novel A2-restricted reverse-transcriptase epitope. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Oct 1;19(2):111-20. PMID: 9768618.